Showing results (521-530 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|August 24, 2006
Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretionXiu-Hua Wu, Hui-Jun Zhou, Jun Lee
Anti-Cancer Drugs|September 1, 2007
Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHPHua Tang, Yuan-Jun Liu, Min Liu, et al.
Anti-Cancer Drugs|September 1, 2007
Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II studyCecilia Nisticò, Emilio Bria, Federica Cuppone, et al.
Anti-Cancer Drugs|September 1, 2007
Distribution of the UGT1A1*28 polymorphism in Caucasian and Asian populations in the US: a genomic analysis of 138 healthy individualsJackie Yao Liu, Kevin Qu, Anthony D Sferruzza, et al.
Anti-Cancer Drugs|September 1, 2007
A pilot study of bendamustine in advanced bile duct cancerKonrad Schoppmeyer, Florian Kreth, Marcus Wiedmann, et al.
Anti-Cancer Drugs|September 1, 2007
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancerCarmelo G Giorgio, Alessandro Pappalardo, Antonio Russo, et al.
Anti-Cancer Drugs|March 4, 2015
Isoflavone lupiwighteone induces cytotoxic, apoptotic, and antiangiogenic activities in DU-145 prostate cancer cellsJie Ren, Qianhui Huang, Yuanyuan Xu, et al.
Anti-Cancer Drugs|March 4, 2015
Increased expression of endoplasmic reticulum protein 29 in lung adenocarcinoma is associated with chemosensitivity to gemcitabineWu Ye, Ruifeng Zhang, Yanjie Hu, et al.
Anti-Cancer Drugs|August 23, 2020
miR-199a-3p suppresses progression of esophageal squamous cell carcinoma through inhibiting mTOR/p70S6K pathwayGuiqin Hou, Yang Wang, Mengying Zhang, et al.
Anti-Cancer Drugs|April 17, 2023
Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcriptionQi Zuo, Qimei Xu, Zhen Li, et al.
Pageof 464